Spinal muscular atrophy type 1: avoidance of hospitalization by respiratory muscle support

Giancarlo Ottonello1, Chiara Mastella, Alessia Franceschi

  • 1U.O. Anestesia e Rianimazione IRCCS G Gaslini, Genoa, Italy.

Insights

A protocol using noninvasive ventilation (NIV) and mechanically assisted coughing (MAC) effectively prevented acute respiratory failure and hospitalizations in young children with spinal muscular atrophy type 1. Caregivers can successfully implement this respiratory support strategy at home.

Area of Science:

  • Pediatric Pulmonology
  • Neuromuscular Disorders
  • Respiratory Care

Background:

  • Spinal muscular atrophy type 1 (SMA1) presents significant respiratory challenges in young children.
  • Respiratory decompensation often leads to continuous noninvasive ventilation (NIV) dependence and oxyhemoglobin desaturation.
  • Effective management strategies are crucial to prevent acute respiratory failure and hospitalizations.

Purpose of the Study:

  • To evaluate an oximetry protocol utilizing continuous NIV and mechanically assisted coughing (MAC).
  • To assess the protocol's efficacy in preventing acute respiratory failure and hospitalizations in children with SMA1 under 3 years.
  • To determine the feasibility of implementing this protocol with trained caregivers in a home setting.

Main Methods:

  • Retrospective chart review of 16 pediatric patients with SMA1 under 3 years.
  • Patients were consecutively referred due to respiratory decompensations and NIV dependence.
  • Protocol involved training parents in NIV, MAC, and basic life support for home use.

Main Results:

  • 49 acute respiratory episodes occurred (1.20/patient/year), with 43 (87.8%) meeting criteria for avoided hospitalization.
  • Only 6 episodes (0.15/patient/year) necessitated hospitalization.
  • Four patients required endotracheal intubation (0.1/patient/year); three were successfully extubated to NIV and MAC.

Conclusions:

  • A protocol combining high-span bilevel positive airway pressure (NIV) and MAC effectively manages airway secretions and normalizes oxygen saturation.
  • Trained caregivers can successfully implement this protocol to avoid acute respiratory failure and hospitalizations in young children with SMA1.
  • This approach offers a viable strategy for home-based respiratory support in SMA1.
Abstract

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...